An annuloplasty device is provided comprising first and second support rings having a coiled configuration in which the first and second support rings are arranged as a coil around a central axis, the first and second support rings are configured to be arranged on opposite sides of native heart valve leaflets of a heart valve, the first and/or second support ring comprises a plurality of sides forming a non-circular cross-section of the first and/or second support ring, wherein the cross-section varies along a longitudinal direction of the first and/or second support ring.

Engageable stents disclosed herein may include an outer stent comprising an elongate body configured to be expandable between a constrained configuration and an unconstrained configuration. The elongate body in the unconstrained configuration may include a retention member and a cylindrical saddle region adjacent the retention member, the cylindrical saddle region defining a lumen extending along a longitudinal axis of the outer stent. The retention member of the outer stent may comprise a double-walled flange. The engageable stents may include an inner stent comprising an elongate body configured to be expandable between a constrained configuration and an unconstrained configuration. The elongate body in the unconstrained configuration may include a retention member and a cylindrical saddle region adjacent the retention member. The retention member of the inner stent may comprise a double-walled flange. The retention members of the outer and inner stent may be removably engageable with each other.

Patient-adapted articular repair systems, including implants, instruments, and surgical plans, and methods of making and using such systems, are disclosed herein. In particular, various embodiments include knee joint articular repair systems designed for posterior stabilization, including patient-adapted posterior-stabilizing features.

An implant system for restoring and improving physiological intracardiac vortical flow in a human heart is provided including a dual force transducting annular implant comprising laterally extending struts transitioning into annular structural members for positioning on the atrial side of the valve annulus; an anchoring system comprising a therapeutic base plate assembly attachable to the apex of the heart; and a tether assembly comprising a tether connected between the implant and the therapeutic base plate assembly.

The present application relates to a stent device deployment apparatus. The apparatus comprises a body having an internal bore for receiving at least a length of sheathed stent device collapsed into an un-deployed state. A bore restriction is provided for restricting passage of any stent device present in the bore to a distal end of the body. The bore restriction is configured for allowing stent device sheath material of a stent device in the bore to be accessed at the distal end of the body and pulled past the bore restriction, thereby exposing the stent device at a proximal end thereof.

The present invention relates to a stent device comprising a sleeve formed with a plurality of compactable spring ring elements arranged along its length, the sleeve having compacted and expanded states. Each said ring element has an undulating profile at the surface of the sleeve so that adjacent ring elements at least partially overlap along the longitudinal extent of the device, the ring elements being compactable against their natural resilience to reduce the outer diameter of the sleeve for allowing housing of the compacted stent device in a frangible sheath, with adjacent ring elements being inter-coupled so as to substantially maintain their axial spacing between the compacted and expanded states.

A kit for preparing an intervertebral disc space for receiving an implant (100) includes a plurality of trials (152) having different sizes. Each trial (152) includes a body (154) insertible into an intervertebral disc space, the body (154) having a leading end (162), a trailing end (164), a top surface (156) and a bottom surface (160), the top surface of the body having a first groove (176) formed therein. Each implant also includes a flange (166) secured to the trailing end (164) of the body (154), the flange (166) having a first channel (180) aligned with the first groove (176), wherein each of the different sized trials has a different flange thickness. The flange thickness controls advancement of a cutting tool such as a chisel (192) into the first groove at the top surface of the trial body, which controls the depth of the cut into vertebral bone.

A method for treating regurgitation of blood flow through a diseased heart valve is provided. The diseased heart valve including an annulus, an anterior valve leaflet, a posterior valve leaflet and a subvalvular apparatus. The method includes providing an apparatus comprising a substantially annular support member, at least one infra-annular support member securely connected thereto, and at least one anchoring element associated with the at least one infra-annular support member. The method further includes attaching the substantially annular support member to the annulus of the diseased heart valve and attaching proximal and distal ends of a prosthetic chordae tendineae to the at least one anchoring element and a papillary muscle, respectively, so that the papillary muscle is caused to move medially.

A side-deliverable prosthetic valve includes an outer frame, a flow control component mounted within the outer frame, and an anchoring element coupled to a distal side of the outer frame. The prosthetic valve is foldable along a longitudinal axis and compressible along a central axis to a compressed configuration for side delivery via a delivery catheter and is expandable to an expanded configuration when released from the delivery catheter. An end portion of the anchoring element is configured to engage a guide wire. The anchoring element is extended during deployment to allow the anchoring element to capture at least one of native leaflet or chordae and, in response to the guide wire being disengaged from the end portion, transitions to a folded configuration to secure at least one of the native leaflet or the chordae between the anchoring element and the distal side of the outer frame.

An occlusion device having a lumen defined therethrough and a saddle narrower than saddles of prior occlusion devices or stents to allow provision of an occlusion element with respect to a portion of the saddle to occlude flow of materials through the saddle. The inner diameter of the narrowed saddle may be 6 mm or less. The occlusion element may be formed from a material which plugs a portion of the occlusion device lumen extending through the saddle and/or which restrains a portion of the saddle from expanding thereby occluding flow of materials therethrough. The remainder of the saddle and/or inwardly facing surfaces of at least one retention member extending outwardly along an end of the saddle may be configured to promote tissue ingrowth, such as by remaining uncoated.